{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:17:28Z","timestamp":1792145848996,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.xphs.2021.12.016","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T02:05:03Z","timestamp":1639706703000},"page":"1497-1508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacokinetic and Pharmacodynamic Evaluation of Gemifloxacin Chitosan Nanoparticles As an Antibacterial Ocular Dosage Form"],"prefix":"10.1016","volume":"111","author":[{"given":"Hatem A.F.M.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir I.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"ElDesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-4990","authenticated-orcid":false,"given":"Ahmed H.","family":"ElShafeey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.12.016_bib0001","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF02849853","article-title":"Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens","volume":"20","author":"Callegan","year":"2003","journal-title":"Adv Ther"},{"key":"10.1016\/j.xphs.2021.12.016_bib0002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bjo.79.6.606","article-title":"Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration","volume":"79","author":"Diamond","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0003","series-title":"Profiles of Drug Substances, Excipients and Related Methodology","first-page":"151","article-title":"Gemifloxacin","author":"Al-Hadiya","year":"2011"},{"key":"10.1016\/j.xphs.2021.12.016_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/45.suppl_3.1","article-title":"Comparative in vitro activity of gemifloxacin","volume":"45","author":"King","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.xphs.2021.12.016_bib0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1089\/jop.2011.0229","article-title":"Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis","volume":"28","author":"Wu","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xphs.2021.12.016_bib0006","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14787210.3.1.131","article-title":"Ocular bacterial infections: current and future treatment options","volume":"3","author":"Kowalski","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.xphs.2021.12.016_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-5173(96)04540-1","article-title":"Lectins in ocular drug delivery: an investigation of lectin binding sites on the corneal and conjunctival surfaces","volume":"138","author":"Nicholls","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0008","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nano.2009.02.003","article-title":"Nanomedicines for ocular NSAIDs: safety on drug delivery","volume":"5","author":"Ara\u00fajo","year":"2009","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.xphs.2021.12.016_bib0009","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/10717544.2014.923065","article-title":"Colloidal drug delivery system: amplify the ocular delivery","volume":"23","author":"Ameeduzzafar","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.12.016_bib0010","first-page":"1","article-title":"A new trend: ocular drug delivery system","volume":"3","author":"Sharma","year":"2011","journal-title":"Int J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.12.016_bib0011","first-page":"251","article-title":"In vitro and in vivo evaluation of Gelrite\u00ae gellan gum-based ocular delivery system for indomethacin","volume":"53","author":"Balasubramaniam","year":"2003","journal-title":"Acta Pharmaceutica-Zagreb"},{"key":"10.1016\/j.xphs.2021.12.016_bib0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-3659(93)90186-9","article-title":"Gellan-based systems for ophthalmic sustained delivery of methylprednisolone","volume":"26","author":"Sanzgiri","year":"1993","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2021.12.016_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.18433\/J3DP43","article-title":"Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations","volume":"17","author":"Almeida","year":"2014","journal-title":"J Pharmacy Pharma Sci"},{"key":"10.1016\/j.xphs.2021.12.016_bib0014","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.progpolymsci.2011.02.001","article-title":"Chitosan\u2014A versatile semi-synthetic polymer in biomedical applications","volume":"36","author":"Dash","year":"2011","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.xphs.2021.12.016_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","article-title":"Recent advances on chitosan-based micro-and nanoparticles in drug delivery","volume":"100","author":"Agnihotri","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2021.12.016_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7897\/2230-8407.041009","article-title":"Formulation and assessment of gemifloxacin mesylate ocular in situ gelling system","volume":"4","author":"Rajalakshmi","year":"2013","journal-title":"Int Res J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7324\/JAPS.2015.501015","article-title":"Chitosan nanoparticles loaded antibiotics as drug delivery biomaterial","volume":"5","author":"Ibrahim","year":"2015","journal-title":"J Appl Pharm Sci"},{"key":"10.1016\/j.xphs.2021.12.016_bib0018","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijbiomac.2014.02.002","article-title":"Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits","volume":"65","author":"Ali","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0019","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.5650\/jos.ess20162","article-title":"Development of oral lipid based nano-formulation of dapagliflozin: optimization, in vitro characterization and ex vivo intestinal permeation study","volume":"69","author":"Zafar","year":"2020","journal-title":"J Oleo Sci"},{"key":"10.1016\/j.xphs.2021.12.016_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijbiomac.2019.06.062","article-title":"Chitosan nanoparticles: Polyphosphates cross-linking and protein delivery properties","volume":"136","author":"Abdelgawad","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.colsurfa.2015.04.006","article-title":"Preparation of chitosan\u2013TPP nanoparticles using microengineered membranes\u2013Effect of parameters and encapsulation of tacrine","volume":"482","author":"Hassani","year":"2015","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.xphs.2021.12.016_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.colsurfb.2011.09.042","article-title":"Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique","volume":"90","author":"Fan","year":"2012","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2021.12.016_bib0023","doi-asserted-by":"crossref","first-page":"59250","DOI":"10.1039\/C6RA06563E","article-title":"Preparation of chitosan nanoparticles by nanoprecipitation and their ability as a drug nanocarrier","volume":"6","author":"Luque-Alcaraz","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2021.12.016_bib0024","doi-asserted-by":"crossref","first-page":"986","DOI":"10.31925\/farmacia.2019.6.8","article-title":"Optimization and influence of some physico-chemical parameters on the synthesis of chitosan-tripolyphosphate nanoparticles","volume":"67","author":"Vasincu","year":"2019","journal-title":"FARMACIA"},{"key":"10.1016\/j.xphs.2021.12.016_bib0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jprot.2007.11.005","article-title":"Preparation of chitosan particles suitable for enzyme immobilization","volume":"70","author":"Bir\u00f3","year":"2008","journal-title":"J Biochem Biophys Methods"},{"key":"10.1016\/j.xphs.2021.12.016_bib0026","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.proche.2014.12.011","article-title":"Encapsulation of risperidone into chitosan-based nanocarrier via ionic binding interaction","volume":"13","author":"Mudhakir","year":"2014","journal-title":"Procedia Chem"},{"key":"10.1016\/j.xphs.2021.12.016_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28659-5","article-title":"Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE)-inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design","volume":"8","author":"Auwal","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2021.12.016_bib0028","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ijbiomac.2018.09.034","article-title":"Tween 80-modified hyaluronic acid-ss-curcumin micelles for targeting glioma: Synthesis, characterization and their in vitro evaluation","volume":"120","author":"Tian","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0029","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.colsurfb.2015.11.050","article-title":"Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles","volume":"139","author":"Ramalingam","year":"2016","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2021.12.016_bib0030","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.2147\/IJN.S139436","article-title":"Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2021.12.016_bib0031","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jddst.2018.12.005","article-title":"Improving therapeutic efficacy of voriconazole against fungal keratitis: Thermo-sensitive in situ gels as ophthalmic drug carriers","volume":"49","author":"Okur","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0032","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jddst.2019.04.012","article-title":"Optimization of Lecithin-Chitosan nanoparticles for simultaneous encapsulation of doxorubicin and piperine","volume":"52","author":"Alkholief","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0033","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1039\/C9RA01133A","article-title":"Mesoporous bioactive glass nanoparticles doped with magnesium: drug delivery and acellular in vitro bioactivity","volume":"9","author":"Tabia","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2021.12.016_bib0034","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1208\/s12249-015-0448-0","article-title":"A novel method for preparing surface-modified fluocinolone acetonide loaded PLGA nanoparticles for ocular use: in vitro and in vivo evaluations","volume":"17","author":"Salama","year":"2016","journal-title":"AAPS Pharmscitech"},{"key":"10.1016\/j.xphs.2021.12.016_bib0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/2230-973X.143114","article-title":"Investigation of moxifloxacin loaded chitosan\u2013dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation","volume":"4","author":"Kaskoos","year":"2014","journal-title":"Int J Pharma Investig"},{"key":"10.1016\/j.xphs.2021.12.016_bib0036","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/2230-973X.177823","article-title":"Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration","volume":"6","author":"Abdullah","year":"2016","journal-title":"Int J Pharma Investig"},{"key":"10.1016\/j.xphs.2021.12.016_bib0037","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.colsurfb.2016.01.014","article-title":"Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability","volume":"141","author":"Zeng","year":"2016","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2021.12.016_bib0038","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","article-title":"Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application","volume":"72","author":"Chhonker","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-5173(92)90274-6","article-title":"Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies","volume":"80","author":"Kyyr\u00f6nen","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1023\/A:1018995923348","article-title":"Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system","volume":"11","author":"Zimmer","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2021.12.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.xphs.2021.12.016_bib0042","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/09273948.2016.1139136","article-title":"Phase-transition W\/O microemulsions for ocular delivery: Evaluation of antibacterial activity in the treatment of bacterial keratitis","volume":"25","author":"Bharti","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0043","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jiac.2013.10.015","article-title":"In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis","volume":"20","author":"Tajima","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.xphs.2021.12.016_bib0044","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijbiomac.2017.11.170","article-title":"Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity","volume":"108","author":"Imam","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/pharmaceutics11010026","article-title":"Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery","volume":"11","author":"Tzeyung","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2021.12.016_bib0046","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(02)00548-3","article-title":"Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles","volume":"250","author":"Xu","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","article-title":"An overview of chitosan nanoparticles and its application in non-parenteral drug delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2021.12.016_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-340","article-title":"Preparation and nanoencapsulation of L-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study","volume":"9","author":"Bahreini","year":"2014","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.xphs.2021.12.016_bib0049","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.colsurfb.2007.04.009","article-title":"Chitosan nanoparticle as protein delivery carrier\u2014systematic examination of fabrication conditions for efficient loading and release","volume":"59","author":"Gan","year":"2007","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2021.12.016_bib0050","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/mp300162j","article-title":"Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate","volume":"9","author":"Koukaras","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0051","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/pat.1306","article-title":"Preparation and properties of ionically cross-linked chitosan nanoparticles","volume":"20","author":"Liu","year":"2009","journal-title":"Polym Adv Technol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0052","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.colsurfb.2010.07.006","article-title":"Kinetics of coacervation transition versus nanoparticle formation in chitosan\u2013sodium tripolyphosphate solutions","volume":"81","author":"Kaloti","year":"2010","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2021.12.016_bib0053","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/nano7120421","article-title":"Improved in vivo efficacy of anti-hypertensive biopeptides encapsulated in chitosan nanoparticles fabricated by ionotropic gelation on spontaneously hypertensive rats","volume":"7","author":"Auwal","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.xphs.2021.12.016_bib0054","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.ejmech.2008.09.045","article-title":"An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion","volume":"44","author":"Khoee","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.xphs.2021.12.016_bib0055","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/nnm.13.136","article-title":"Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention","volume":"9","author":"Meng","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2021.12.016_bib0056","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/10717544.2017.1377315","article-title":"Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice","volume":"24","author":"Yadav","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.12.016_bib0057","first-page":"1170","article-title":"Formulation, characterisation and evaluation of sustained release microcapsules of gemifloxacin","volume":"6","author":"Tadudari","year":"2014","journal-title":"Int J PharmTech Res"},{"key":"10.1016\/j.xphs.2021.12.016_bib0058","series-title":"Formulation Optimization And Evaluation of Orally Disintegrating Tablets Of Gemifloxacin Mesylate","author":"Bhupendra","year":"2021"},{"key":"10.1016\/j.xphs.2021.12.016_bib0059","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijbiomac.2009.07.006","article-title":"Physicochemical and bioactivity of cross-linked chitosan\u2013PVA film for food packaging applications","volume":"45","author":"Tripathi","year":"2009","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.carbpol.2009.02.019","article-title":"Evaluation of Alginate\/Chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization","volume":"77","author":"Gazori","year":"2009","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2021.12.016_bib0061","series-title":"Biopolymeric Nanoparticles for Oral Protein Delivery: Design and, in, Vitro","author":"Elgindy","year":"2011"},{"key":"10.1016\/j.xphs.2021.12.016_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-018-1279-6","article-title":"An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery","volume":"20","author":"Nair","year":"2019","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.xphs.2021.12.016_bib0063","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijbiomac.2014.05.035","article-title":"Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles","volume":"69","author":"Pooja","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0064","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.colsurfb.2014.10.047","article-title":"Surface engineering of silica nanoparticles for oral insulin delivery: Characterization and cell toxicity studies","volume":"123","author":"Andreani","year":"2014","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.xphs.2021.12.016_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10847-016-0625-0","article-title":"Synthesis, identification and in vitro drug release of layered zinc hydroxide-gemifloxacin nanohybrids","volume":"85","author":"Nabipour","year":"2016","journal-title":"J Inclusion Phenom Macrocyclic Chem"},{"key":"10.1016\/j.xphs.2021.12.016_bib0066","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ijbiomac.2017.08.057","article-title":"Size optimization and in vitro biocompatibility studies of chitosan nanoparticles","volume":"104","author":"Thandapani","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0067","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.powtec.2010.08.066","article-title":"Production and characterization of chitosan microparticles containing papain for controlled release applications","volume":"205","author":"Vasconcellos","year":"2011","journal-title":"Powder Technol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0068","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.foodhyd.2018.12.027","article-title":"Green synthesis, characterization and in vitro release of cinnamaldehyde\/sodium alginate\/chitosan nanoparticles","volume":"90","author":"Ji","year":"2019","journal-title":"Food Hydrocoll"},{"key":"10.1016\/j.xphs.2021.12.016_bib0069","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijbiomac.2016.10.068","article-title":"Chitosan nanoparticles enhances the anti-quorum sensing activity of kaempferol","volume":"94","author":"Ilk","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.carbpol.2017.07.030","article-title":"Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model","volume":"174","author":"Abdelkader","year":"2017","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2021.12.016_bib0071","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0072","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4718045","article-title":"Preparation and drug release study of novel nanopharmaceuticals with polysorbate 80 surface adsorption","volume":"2018","author":"Tao","year":"2018","journal-title":"J Nanomat"},{"key":"10.1016\/j.xphs.2021.12.016_bib0073","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/313961","article-title":"5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics","volume":"2012","author":"T\u0131\u011fl\u0131 Ayd\u0131n","year":"2012","journal-title":"J Nanomat"},{"key":"10.1016\/j.xphs.2021.12.016_bib0074","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1208\/s12249-016-0669-x","article-title":"Development of timolol-loaded galactosylated chitosan nanoparticles and evaluation of their potential for ocular drug delivery","volume":"18","author":"Zhao","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2021.12.016_bib0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nano.2009.04.001","article-title":"Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine","volume":"6","author":"Wilson","year":"2010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.xphs.2021.12.016_bib0076","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0077","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/10837450.2014.910807","article-title":"Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization","volume":"20","author":"Khan","year":"2015","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0078","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1023\/A:1018931210396","article-title":"Zero-order drug release from hydrocolloid matrices","volume":"10","author":"M\u00f6ckel","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2021.12.016_bib0079","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II. Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2021.12.016_bib0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.carbpol.2007.11.007","article-title":"Chitosan nanoparticles loaded with dorzolamide and pramipexole","volume":"73","author":"Papadimitriou","year":"2008","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2021.12.016_bib0081","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","article-title":"Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits","volume":"443","author":"Tayel","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0082","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0083","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0924-8579(00)00142-4","article-title":"Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation","volume":"14","author":"AliAbadi","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xphs.2021.12.016_bib0084","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ophtha.2014.06.049","article-title":"Antibiotic resistance in acute postoperative endophthalmitis","volume":"121","author":"Holland","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xphs.2021.12.016_bib0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1517\/17460441.2.6.849","article-title":"Integration of pharmacokinetic\/pharmacodynamic modeling and simulation in the development of new anti-infective agents\u2013minimum inhibitory concentration versus time-kill curves","volume":"2","author":"Schmidt","year":"2007","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.xphs.2021.12.016_bib0086","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/jop.2010.0054","article-title":"Ocular pharmacokinetics\/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits","volume":"26","author":"Proksch","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xphs.2021.12.016_bib0087","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0301-4738.16676","article-title":"Pharmacokinetics of topically applied sparfloxacin in rabbits","volume":"53","author":"Satia","year":"2005","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xphs.2021.12.016_bib0088","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2014.10.035","article-title":"Corneal targeted nanoparticles for sustained natamycin delivery and their PK\/PD indices: an approach to reduce dose and dosing frequency","volume":"477","author":"Chandasana","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.016_bib0089","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clinthera.2010.03.013","article-title":"Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis","volume":"32","author":"Chang","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.xphs.2021.12.016_bib0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1198-743x.2001.00297.x","article-title":"Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates","volume":"7","author":"Gonullu","year":"2001","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:38:51Z","timestamp":1758361131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921006948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0022354921006948"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.12.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and Pharmacodynamic Evaluation of Gemifloxacin Chitosan Nanoparticles As an Antibacterial Ocular Dosage Form","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}